Search

Your search keyword '"James, Stefan"' showing total 2,291 results
Start Over Author "James, Stefan"
2,291 results on '"James, Stefan"'

51. Medical treatment of heart failure with renin–angiotensin–aldosterone system inhibitors and beta-blockers in aortic stenosis: association with long-term outcome after aortic valve replacement.

Author

Hopfgarten, Johan, James, Stefan, Lindhagen, Lars, Baron, Tomasz, Ståhle, Elisabeth, and Christersson, Christina

Subjects
AORTIC valve transplantation, HEART failure, ADRENERGIC beta blockers, AORTIC stenosis, THERAPEUTICS, RENIN-angiotensin system
Abstract

Aims There is a lack of robust data on the optimal medical treatment of heart failure in patients with severe aortic stenosis, with no randomized controlled trials guiding treatment. The study aimed to study the association between exposure to renin–angiotensin–aldosterone system (RAS) inhibitors or beta-blockers and outcome after aortic valve replacement in patients with aortic stenosis and heart failure. Methods and results The study included all patients with heart failure undergoing aortic valve replacement for aortic stenosis in Sweden between 2008 and 2016 (n = 4668 patients). Exposure to treatment was assessed by a continuous tracking of drug dispensations, and outcome events were all-cause mortality and hospitalization for heart failure collected from national patient registries. After adjustment for age, sex, atrial fibrillation, hypertension, diabetes mellitus, and prior myocardial infarction, Cox regression analysis showed that RAS inhibition was associated with a lower risk of all-cause mortality in patients with reduced left ventricular ejection fraction (LV-EF) [hazard ratio (HR) 0.58, 95% confidence interval (CI) 0.51–0.65] and preserved LV-EF (HR 0.69, 95% CI 0.56–0.85). Beta-blockade was associated with a lower risk of all-cause mortality in patients with reduced LV-EF (HR 0.81, 95% CI 0.71–0.92), but not in preserved LV-EF (HR 0.87, 95% CI 0.69–1.10). There was no association between RAS inhibition or beta-blockade and the risk of hospitalization for heart failure. Conclusion The RAS inhibition was associated with a lower all-cause mortality after valve replacement in patients with both reduced and preserved LV-EF. Beta-blockade was associated with lower all-cause mortality only in patients with reduced LV-EF. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

55. Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Author

James, Stefan, primary, Erlinge, David, additional, Storey, Robert F., additional, McGuire, Darren K., additional, de Belder, Mark, additional, Eriksson, Niclas, additional, Andersen, Kasper, additional, Austin, David, additional, Arefalk, Gabriel, additional, Carrick, David, additional, Hofmann, Robin, additional, Hoole, Stephen P., additional, Jones, Daniel A., additional, Lee, Kelvin, additional, Tygesen, Hans, additional, Johansson, Peter A., additional, Langkilde, Anna Maria, additional, Ridderstråle, Wilhelm, additional, Parvaresh Rizi, Ehsan, additional, Deanfield, John, additional, and Oldgren, Jonas, additional

Published
2023
Full Text
View/download PDF

59. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial

Author

Wood, David A., Cairns, John A., Wang, Jia, Mehran, Roxana, Storey, Robert F., Nguyen, Helen, Meeks, Brandi, Kunadian, Vijay, Tanguay, Jean-Francois, Kim, Hahn-Ho, Cheema, Asim, Dehghani, Payam, Natarajan, Madhu K., Jolly, Sanjit S., Amerena, John, Keltai, Matyas, James, Stefan, Hlinomaz, Ota, Niemela, Kari, AlHabib, Khalid, Lewis, Basil S., Nguyen, Michel, Sarma, Jaydeep, Dzavik, Vladimir, Della Siega, Anthony, and Mehta, Shamir R.

Published
2019
Full Text
View/download PDF

63. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease

Author

Capodanno, Davide, Bhatt, Deepak L., Eikelboom, John W., Fox, Keith A. A., Geisler, Tobias, Michael Gibson, C., Gonzalez-Juanatey, Jose Ramon, James, Stefan, Lopes, Renato D., Mehran, Roxana, Montalescot, Gilles, Patel, Manesh, Steg, P. Gabriel, Storey, Robert F., Vranckx, Pascal, Weitz, Jeffrey I., Welsh, Robert, Zeymer, Uwe, and Angiolillo, Dominick J.

Published
2020
Full Text
View/download PDF

64. Direct or subacute coronary angiography in out-of-hospital cardiac arrest (DISCO)—An initial pilot-study of a randomized clinical trial

Author

Elfwén, Ludvig, Lagedal, Rickard, Nordberg, Per, James, Stefan, Oldgren, Jonas, Böhm, Felix, Lundgren, Peter, Rylander, Christian, van der Linden, Jan, Hollenberg, Jacob, Erlinge, David, Cronberg, Tobias, Jensen, Ulf, Friberg, Hans, Lilja, Gisela, Larsson, Ing-Marie, Wallin, Ewa, Rubertsson, Sten, and Svensson, Leif

Published
2019
Full Text
View/download PDF

66. Left atrial dysfunction in bicuspid aortic valve patients with severe aortic stenosis is associated with post-operative atrial fibrillation following aortic valve replacement.

Author

Wedin, Johan O., Rodin, Sergey, Flachskampf, Frank A., Simonson, Oscar E., Pallin, Johan, Malmborg, Jonathan Hörsne, James, Stefan K., Ståhle, Elisabeth, and Grinnemo, Karl-Henrik

Subjects
AORTIC valve transplantation, MITRAL valve, AORTIC valve, LEFT heart atrium, AORTIC stenosis, HEART valve prosthesis implantation
Abstract

Aims: To investigate (i) the association between pre-operative left atrial (LA) reservoir strain and post-operative atrial fibrillation (AF) and (ii) the incidence of post-operative ischaemic stroke events separately in bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) patients after surgical aortic valve replacement for isolated severe aortic stenosis (AS). Methods and results: We prospectively enrolled 227 patients (n = 133 BAV and n = 94 TAV) with isolated severe AS scheduled for aortic valve replacement. A comprehensive intra- and inter-observer validated pre-operative echocardiogram with an analysis of LA reservoir strain was performed. Post-operative AF was defined as a sustained (>30 s) episode of AF or atrial flutter. The timing of neurological events was defined in accordance with the Valve Academic Research Consortium-3 criteria for stroke. Post-operative AF occurred in 114 of 227 patients (50.2%), with no difference between BAV and TAV patients (48.1 vs. 53.1%, P = 0.452). Persisting post-operative AF at discharge was more frequent in BAV patients (29.7 vs. 8.0%, P = 0.005). Pre-operative LA reservoir strain was independently associated with post-operative AF (odds ratio = 1.064, 95% confidence interval 1.032-1.095, P < 0.001), with a significant interaction between LA reservoir strain and aortic valve morphology (Pinteraction = 0.002). The cumulative transient ischemic attack (TIA)/stroke incidence during follow-up was significantly higher in BAV patients (19.1 vs. 5.8% at 5 years). Conclusion: Pre-operative LA function was associated with post-operative AF after aortic valve replacement in BAV AS patients, while post-operative AF in TAV AS patients likely depends on transient post-operative alterations and traditional cardiovascular risk factors. TIA/stroke during follow-up was more common in BAV AS patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

67. Effects of pharmacological interventions on short- and long-term mortality in patients with takotsubo syndrome: a report from the SWEDEHEART registry

Author

Petursson, Petur, primary, Oštarijaš, Eduard, additional, Redfors, Bjorn, additional, Råmunddal, Truls, additional, Angerås, Oskar, additional, Völz, Sebastian, additional, Rawshani, Araz, additional, Hambraeus, Kristina, additional, Koul, Sasha, additional, Alfredsson, Joakim, additional, Hagström, Henrik, additional, Loghman, Hanereh, additional, Hofmann, Robin, additional, Fröbert, Ole, additional, Jernberg, Tomas, additional, James, Stefan, additional, Erlinge, David, additional, and Omerovic, Elmir, additional

Published
2023
Full Text
View/download PDF

68. Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial

Author

Tank, Amarjeet, primary, Johnston, S Claiborne, additional, Jain, Ritika, additional, Amarenco, Pierre, additional, Mellström, Carl, additional, Rikner, Klas, additional, Denison, Hans, additional, Ladenvall, Per, additional, Knutsson, Mikael, additional, Himmelmann, Anders, additional, Evans, Scott R, additional, James, Stefan, additional, Molina, Carlos A, additional, Wang, Yongjun, additional, and Ouwens, Mario, additional

Published
2023
Full Text
View/download PDF

69. Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review

Author

Hoogervorst, Lotje A., primary, Geurkink, Timon H., additional, Lübbeke, Anne, additional, Buccheri, Sergio, additional, Schoones, Jan W., additional, Torre, Marina, additional, Laricchiuta, Paola, additional, Piscoi, Paul, additional, Pedersen, Alma B., additional, Gale, Chris P., additional, Smith, James A., additional, Maggioni, Aldo P., additional, James, Stefan, additional, Fraser, Alan G., additional, Nelissen, Rob G.H.H., additional, and Marang-van de Mheen, Perla J., additional

Published
2023
Full Text
View/download PDF

75. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score

Author

Raposeiras-Roubín, Sergio, Faxén, Jonas, Íñiguez-Romo, Andrés, Henriques, Jose Paulo Simao, D'Ascenzo, Fabrizio, Saucedo, Jorge, Szummer, Karolina, Jernberg, Tomas, James, Stefan K., Juanatey, José Ramón González, Wilton, Stephen B., Kikkert, Wouter J., Nuñez-Gil, Iván, Ariza-Sole, Albert, Song, Xiantao, Alexopoulos, Dimitrios, Liebetrau, Christoph, Kawaji, Tetsuma, Moretti, Claudio, Huczek, Zenon, Nie, Shao-Ping, Fujii, Toshiharu, Correia, Luis, Kawashiri, Masa-aki, Caneiro-Queija, Berenice, Cobas-Paz, Rafael, Acuña, José María García, Southern, Danielle, Alfonso, Emilio, Terol, Belén, Garay, Alberto, Zhang, Dongfeng, Chen, Yalei, Xanthopoulou, Ioanna, Osman, Neriman, Möllmann, Helge, Shiomi, Hiroki, Giordana, Francesca, Gaita, Fiorenzo, Kowara, Michal, Filipiak, Krzysztof, Wang, Xiao, Yan, Yan, Fan, Jing-Yao, Ikari, Yuji, Nakahayshi, Takuya, Sakata, Kenji, Yamagishi, Masakazu, Kalpak, Oliver, Kedev, Sasko, Rivera-Asenjo, Daniel, and Abu-Assi, Emad

Published
2018
Full Text
View/download PDF

78. Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum]

Author

Ludvigsson, Jonas F, primary, Appelros, Peter, additional, Askling, Johan, additional, Byberg, Liisa, additional, Carrero, Juan-Jesus, additional, Ekström, Anna Mia, additional, Ekström, Magnus, additional, Smedby, Karin Ekström, additional, Hagström, Hannes, additional, James, Stefan, additional, Järvholm, Bengt, additional, Michaelsson, Karl, additional, Pedersen, Nancy L, additional, Sundelin, Helene, additional, Sundquist, Kristina, additional, and Sundström, Johan, additional

Published
2023
Full Text
View/download PDF

80. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

Author

Valgimigli, Marco, primary, Aboyans, Victor, additional, Angiolillo, Dominick, additional, Atar, Dan, additional, Capodanno, Davide, additional, Halvorsen, Sigrun, additional, James, Stefan, additional, Jüni, Peter, additional, Kunadian, Vijay, additional, Landi, Antonio, additional, Leonardi, Sergio, additional, Mehran, Roxana, additional, Montalescot, Gilles, additional, Navarese, Eliano Pio, additional, Niebauer, Josef, additional, Oliva, Angelo, additional, Piccolo, Raffaele, additional, Price, Susanna, additional, Storey, Robert F, additional, Völler, Heinz, additional, Vranckx, Pascal, additional, Windecker, Stephan, additional, and Fox, Keith A A, additional

Published
2023
Full Text
View/download PDF

83. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

Author

Ohman, E Magnus, Roe, Matthew T, Steg, P Gabriel, James, Stefan K, Povsic, Thomas J, White, Jennifer, Rockhold, Frank, Plotnikov, Alexei, Mundl, Hardi, Strony, John, Sun, Xiang, Husted, Steen, Tendera, Michal, Montalescot, Gilles, Bahit, M Cecilia, Ardissino, Diego, Bueno, Héctor, Claeys, Marc J, Nicolau, Jose C, Cornel, Jan H, Goto, Shinya, Kiss, Róbert Gábor, Güray, Ümit, Park, Duk-Woo, Bode, Christoph, Welsh, Robert C, and Gibson, C Michael

Published
2017
Full Text
View/download PDF

84. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

Author

Costa, Francesco, van Klaveren, David, James, Stefan, Heg, Dik, Räber, Lorenz, Feres, Fausto, Pilgrim, Thomas, Hong, Myeong-Ki, Kim, Hyo-Soo, Colombo, Antonio, Steg, Philippe Gabriel, Zanchin, Thomas, Palmerini, Tullio, Wallentin, Lars, Bhatt, Deepak L, Stone, Gregg W, Windecker, Stephan, Steyerberg, Ewout W, and Valgimigli, Marco

Published
2017
Full Text
View/download PDF

88. Plasma Neurofilament Light Chain Is Elevated after Transcatheter Aortic Valve Implantation.

Author

Sjölin, Karl, Christersson, Christina, James, Stefan, Lindbäck, Johan, Åsberg, Signild, and Burman, Joachim

Subjects
HEART valve prosthesis implantation, CYTOPLASMIC filaments, BIOMARKERS
Abstract

Introduction: Transcatheter aortic valve implantation (TAVI) is associated with a high incidence of new silent brain infarcts (SBIs) on postprocedural neuroimaging. A venous blood sample reflecting neuronal damage following TAVI could help identify patients with potential SBIs. We aimed to investigate if a biochemical marker of neuronal injury, neurofilament light chain (NFL), is elevated after TAVI. Methods: In this observational study, NFL was measured in plasma from 31 patients before and after TAVI. Multivariable regression analysis was performed to investigate any effect of clinical- and procedure-related factors on differences in NFL levels before and after TAVI. Results: Samples were collected 41 (14–81) days before and 44 (35–59) days after TAVI, median (interquartile range). Median age was 81 (77–84) years, and 35% were female. No patient had any overt procedure-related neurological complications. The geometric mean (95% confidence interval) of the NFL concentration was 30 (25–36) pg/mL before TAVI and 48 (39–61) pg/mL, after TAVI, p <0.001. None of the included variables in the multiple linear regression model were statistically significantly associated with the difference in levels before and after TAVI. Conclusions: NFL levels in plasma were higher after TAVI as compared with levels before, with a mean increase of 60% (18 pg/mL). Further studies including neuroimaging and cognitive outcomes are needed to understand the potential value of measuring NFL in relation to TAVI. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

89. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Author

Rao, Sunil V., primary, Kirsch, Bodo, additional, Bhatt, Deepak L., additional, Budaj, Andrzej, additional, Coppolecchia, Rosa, additional, Eikelboom, John, additional, James, Stefan K., additional, Jones, W. Schuyler, additional, Merkely, Bela, additional, Keller, Lars, additional, Hermanides, Renicus S., additional, Campo, Gianluca, additional, Ferreiro, José Luis, additional, Shibasaki, Taro, additional, Mundl, Hardi, additional, Alexander, John H., additional, Hengstenberg, Christian, additional, Steinwender, Clemens, additional, Alber, Hannes, additional, Steringer-Mascherbauer, Regina, additional, Schober, Andreas, additional, Auer, Johann, additional, Roithinger, Franz Xaver, additional, von Lewinski, Dirk, additional, Moertl, Deddo, additional, Huber, Kurt, additional, Coussement, Patrick, additional, Hoffer, Etienne, additional, Beauloye, Christophe, additional, Janssens, Luc, additional, Vranckx, Pascal, additional, De Raedt, Herbert, additional, Vanassche, Thomas, additional, Vrolix, Matthias, additional, Rokyta, Richard, additional, Parenica, Jiri, additional, Pelouch, Radek, additional, Motovska, Zuzanna, additional, Alan, David, additional, Kettner, Jiri, additional, Polasek, Rostislav, additional, Cermak, Ondrej, additional, Sedlon, Pavel, additional, Hanis, Jiri, additional, Novak, Martin, additional, Belohlavek, Jan, additional, Horacek, Thomas, additional, Leggewie, Stefan, additional, Wenzel, Philip, additional, vom Dahl, Juergen, additional, Sievers, Burkhard, additional, Pulz, Jan, additional, Schellong, Sebastian, additional, Clemmensen, Peter, additional, Muller-Hennessen, Matthias, additional, Rassaf, Tienush, additional, Falukozi, Jozsef, additional, Ruzsa, Zoltan, additional, Tomcsanyi, Janos, additional, Csanadi, Zoltan, additional, Herczeg, Bela, additional, Koszegi, Zsolt, additional, Vorobcsuk, Andras, additional, Kiss, Robert, additional, Baranyai, Csaba, additional, Dezsi, Csaba, additional, Lupkovics, Geza, additional, Rossini, Roberta, additional, Scherillo, Marino, additional, Sergio Saba, Pier, additional, Calogero Campo, Gianluca, additional, Calo, Leonardo, additional, Nassiacos, Daniele, additional, Quadri, Giorgio, additional, Sciahbasi, Alessandro, additional, Silvio Marenzi, Gian Carlo, additional, Reimers, Bernhard, additional, Perna, Gian Piero, additional, Sacca, Salvatore, additional, Fattore, Luciano, additional, Brunelli, Claudio, additional, Picchi, Andrea, additional, Kuramochi, Takehiko, additional, Kondo, Kazuhisa, additional, Aoyama, Takahiko, additional, Kudoh, Takashi, additional, Yamamoto, Tadashi, additional, Takaya, Tomofumi, additional, Mukai, Yasushi, additional, Fukui, Kazuki, additional, Morioka, Nobuyuki, additional, Ando, Kenji, additional, Yamamuro, Atsushi, additional, Morita, Yasuhiro, additional, Koga, Yasuaki, additional, Watanabe, Tetsuya, additional, Sakamoto, Tomohiro, additional, Maebuchi, Daisuke, additional, Takahashi, Akihiko, additional, Yonetsu, Taishi, additional, Kakuta, Tsunekazu, additional, Nishina, Hidetaka, additional, Oemrawsingh, Rohit, additional, Dorman, Reinhart, additional, Oude Ophius, Ton, additional, Prins, Paco, additional, al Windy, N.Y.Y., additional, Zoet-Nugteren, S.K., additional, Hermanides, Rik, additional, van Eck, Martijn, additional, Scherptong, Roderick, additional, Cornel, J.H., additional, Damman, Peter, additional, Bech, Gerhard, additional, Torquay, R., additional, Kietselaer, Bas, additional, Grzelakowski, Pawel, additional, Krzysztof, Dyrbus, additional, Miekus, Pawel, additional, Przybylski, Andrzej, additional, Zarebinski, Maciej, additional, Balsam, Pawel, additional, Szachniewicz, Joanna, additional, Gierlotka, Marek, additional, Tycinska, Agnieszka, additional, Iniguez Romo, Andres, additional, Fernandez Ortiz, Antonio, additional, Carrasquer Cucarella, Anna, additional, Sanmartin Fernandez, Marcelo, additional, Sionis, Alessandro, additional, Bueno Zamora, Hector, additional, Ferreiro Gutierrez, Jose Luis, additional, Almenar, Luis, additional, Ferreira Gonzalez, Ignacio, additional, Pascual Figal, Domingo A., additional, Almendro Delia, Manuel, additional, Jimenez Fernandez, Miriam, additional, Skeppholm, Mika, additional, Zedigh, Crister, additional, Angeras, Oskar, additional, Lauermann, Jorg, additional, Erlinge, David, additional, Gustafsson, Robin, additional, Mooe, Thomas, additional, Utreras, Alejandro, additional, James, Stefan, additional, Grimfjard, Per, additional, Pedrazzini, Giovanni, additional, Mach, Francois, additional, Fournier, Stephane, additional, Haegeli, Laurent, additional, Beer, Jurg H., additional, Leibundgut, Gregor, additional, Kobza, Richard, additional, Kaiser, Christoph, additional, Kunadian, Vijay, additional, Al-Lamee, Rasha, additional, Gorog, Diana, additional, Khan, Sohail, additional, Trevelyan, Jasper, additional, Toor, Iqbal, additional, Smith, James, additional, Purushottam, Bhaskar, additional, Treasure, Charles, additional, Arena, Frank, additional, Vedere, Amarnath, additional, Henderson, David, additional, Gilani, Syed, additional, Jones, Alonzo, additional, Carrillo-Jimenez, Rodolfo, additional, Gillespie, Eve, additional, Marhefka, Gregary, additional, Wang, David, additional, Olson, Charles, additional, Bloom, Stephen, additional, Iftikhar, Faizan, additional, Brabham, David, additional, McGinty, John, additional, Thompson, Charles, additional, Talano, James, additional, Ginete, Wilson, additional, Williams, Marcus, additional, Masud, Ali, additional, Ariani, Mehrdad, additional, Bitar, Fahed, additional, Wang, Thomas, additional, and Samuelson, Bradley, additional

Published
2022
Full Text
View/download PDF

90. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

Author

Mahmoodi, Bakhtawar K., Tragante, Vinicius, Kleber, Marcus E., Holmes, Michael V., Schmidt, Amand F., McCubrey, Raymond O., Howe, Laurence J., Direk, Kenan, Allayee, Hooman, Baranova, Ekaterina V., Braund, Peter S., Delgado, Graciela E., Eriksson, Niclas, Gijsberts, Crystel M., Gong, Yan, Hartiala, Jaana, Heydarpour, Mahyar, Pasterkamp, Gerard, Kotti, Salma, Kuukasjärvi, Pekka, Lenzini, Petra A., Levin, Daniel, Lyytikäinen, Leo-Pekka, Muehlschlegel, Jochen D., Nelson, Christopher P., Nikus, Kjell, Pilbrow, Anna P., Wilson Tang, W.H., van der Laan, Sander W., van Setten, Jessica, Vilmundarson, Ragnar O., Deanfield, John, Deloukas, Panos, Dudbridge, Frank, James, Stefan, Mordi, Ify R, Teren, Andrej, Bergmeijer, Thomas O., Body, Simon C., Bots, Michiel, Burkhardt, Ralph, Cooper-DeHoff, Rhonda M., Cresci, Sharon, Danchin, Nicolas, Doughty, Robert N., Grobbee, Diederick E., Hagström, Emil, Hazen, Stanley L., Held, Claes, Hoefer, Imo E., Hovingh, G. Kees, Johnson, Julie A., Kaczor, Marcin P., Kähönen, Mika, Klungel, Olaf H., Laurikka, Jari O., Lehtimäki, Terho, Maitland-van der Zee, Anke H., McPherson, Ruth, Palmer, Colin N., Kraaijeveld, Adriaan O., Pepine, Carl J., Sanak, Marek, Sattar, Naveed, Scholz, Markus, Simon, Tabassome, Spertus, John A., Stewart, Alexandre F.R., Szczeklik, Wojciech, Thiery, Joachim, Visseren, Frank L.J., Waltenberger, Johannes, Richards, A. Mark, Lang, Chim C., Cameron, Vicky A., Åkerblom, Axel, Pare, Guillaume, März, Winfried, Samani, Nilesh J., Hingorani, Aroon D., ten Berg, Jurriën M., Wallentin, Lars, Asselbergs, Folkert W., and Patel, Riyaz S.

Published
2020
Full Text
View/download PDF

98. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

Author

Navarese, Eliano Pio, primary, Landi, Antonio, additional, Oliva, Angelo, additional, Piccolo, Raffaele, additional, Aboyans, Victor, additional, Angiolillo, Dominick, additional, Atar, Dan, additional, Capodanno, Davide, additional, Fox, Keith A A, additional, Halvorsen, Sigrun, additional, James, Stefan, additional, Jüni, Peter, additional, Kunadian, Vijay, additional, Leonardi, Sergio, additional, Mehran, Roxana, additional, Montalescot, Gilles, additional, Niebauer, Josef, additional, Price, Susanna, additional, Storey, Robert F, additional, Völler, Heinz, additional, Vranckx, Pascal, additional, Windecker, Stephan, additional, and Valgimigli, Marco, additional

Published
2023
Full Text
View/download PDF

99. Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Author

Davidsson, Pia, primary, Eketjäll, Susanna, additional, Eriksson, Niclas, additional, Walentinsson, Anna, additional, Becker, Richard C, additional, Cavallin, Anders, additional, Bogstedt, Anna, additional, Collén, Anna, additional, Held, Claes, additional, James, Stefan, additional, Siegbahn, Agneta, additional, Stewart, Ralph, additional, Storey, Robert S, additional, White, Harvey, additional, and Wallentin, Lars, additional

Published
2023
Full Text
View/download PDF

100. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II

Author

Gyldenkerne, Christine, primary, Maeng, Michael, additional, Kjøller-Hansen, Lars, additional, Maehara, Akiko, additional, Zhou, Zhipeng, additional, Ben-Yehuda, Ori, additional, Erik Bøtker, Hans, additional, Engstrøm, Thomas, additional, Matsumura, Mitsuaki, additional, Mintz, Gary S., additional, Fröbert, Ole, additional, Persson, Jonas, additional, Wiseth, Rune, additional, Larsen, Alf I., additional, Jensen, Lisette O., additional, Nordrehaug, Jan E., additional, Bleie, Øyvind, additional, Omerovic, Elmir, additional, Held, Claes, additional, James, Stefan K., additional, Ali, Ziad A., additional, Rosen, Hans C., additional, Stone, Gregg W., additional, and Erlinge, David, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results